SEC Form 4 · accession 0001493152-26-040129
EXOZYMES INC. · EXOZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Damien Alan Perriman
Officer — Chief Commercial Officer
Period of report
Aug 19, 2026
Accepted (ET)
Aug 25, 2026 · 7:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002010788
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2026 | M | 19,612 | — | A | 28,499 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Aug 19, 2026 | M | 19,612 | D | — | — | Common Stock | 19,612 | 43,147 | D |
Explanation of responses
- F1The RSU convert on a one-for-one basis.
- F2On January 14, 2026, the reporting person was granted an aggregate of 62,759 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 19,612 shares of common stock.